Advertisement
News
Subscribe to MDT Magazine News

Podcast: Student Innovation Holds Promise for Breast Cancer Screening

March 31, 2011 12:32 pm | by Diagnostic Imaging | Comments

Imagine a faster, inexpensive method for breast cancer screening. That's some of the promise behind a new innovation from doctoral student, Sevan Goenezen, who has discovered a way to use ultrasound and advanced algorithms to differentiate between benign and malignant tumors.

TOPICS:

Class I Medical Device Recall: Millar Instruments Inc., Mikro-Tip Angiographic Catheter, Model SPC-454D and SPC-454F

March 31, 2011 11:37 am | by U.S. Food & Drug Administration | Comments

This device measures pressure within the blood vessels. It is capable of delivering high-speed injection of material that is not absorbed into the body (radiopaque contrast media). This material is then used to view blood vessels.

A new signaling pathway of the immune system is elucidated

March 31, 2011 10:38 am | by EurekAlert | Comments

(Goethe University Frankfurt) A new signaling pathway, which is important for the regulation of the immune response and inflammation, was discovered by an international team of scientists led by prof Ivan Dikic from the Goethe University, Frankfurt, Germany. The scientists studied...

TOPICS:
Advertisement

Biogen begins ALS treatment trial, pays $10M to Knopp

March 31, 2011 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Biogen Idec and its partner Knopp Biosciences have launched a Phase 3 trial for their potential treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease. In connection with the launch, Biogen will pay a $10 million milestone payment to Knopp.

Patients with severe non-inflammatory respiratory disease face anemia risk

March 31, 2011 10:33 am | by EurekAlert | Comments

(Wiley-Blackwell) The links between chronic obstructive pulmonary disease and anemia are already well known, but now a study of nearly 600 patients has found that anemia is also frequently found in patients with severe non-inflammatory respiratory diseases.

TOPICS:

AAIPharma Services Announces Promotion of Dean Shirazi

March 31, 2011 9:35 am | by Bio-Medicine.Org | Comments

WILMINGTON, N.C., March 31, 2011 /- AAIPharma Services Corp., a leading provider of pharmaceutical product development and manufacturing services, announced today the promotion of Dean Shirazi, Ph.D., to Vice President, Analytical Development. Shirazi will assume the position effective...

TOPICS:

Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad

March 31, 2011 9:35 am | by Bio-Medicine.Org | Comments

ATLANTA, March 31, 2011 /- Digital Assent has expanded its leadership team to meet the rapidly growing demand for its award-winning PatientPad® solution.  The PatientPad is a self-service patient check-in and education solution designed to automate the patient intake process and...

TOPICS:

Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium

March 31, 2011 9:35 am | by Bio-Medicine.Org | Comments

RAMSEY, N.J., March 31, 2011 /- Top medical device manufacturers are supporting MPO Symposium Costa Rica, the leading medical device manufacturing conference series. Hologic, Hospira, Boston Scientific, Allergan, Siemens, as well as the Costa Rican government are active participants in...

TOPICS:
Advertisement

Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis

March 31, 2011 9:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 31, 2011 /- Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind  Phase II clinical trial of obeticholic acid (OCA) given as monotherapy to patients with primary biliary cirrhosis (PBC).  The study...

TOPICS:

OncoSec Medical Closes $1.1M Financing

March 31, 2011 9:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 31, 2011 /- OncoSec Medical Inc. (OTC BB: ONCS), a developer of innovative medical approaches to treat solid tumor cancers, announced today that it has raised more than $1 million of new capital through the issuance of units to three institutional investors. OncoSec...

TOPICS:

Del. judge rules in pacemaker patent dispute

March 31, 2011 8:45 am | by The Associated Press | Comments

A federal judge in Delaware has ruled that certain heart pacemakers sold by Medtronic Inc. do not infringe patents claimed by rival medical device manufacturer Boston Scientific Corp.Ruling in a long-running dispute between the two companies, the judge granted a request by Minneapolis-based...

Fluvastatin enhances HCV response in combination with interferon and ribavirin

March 31, 2011 8:39 am | by EurekAlert | Comments

(European Association for the Study of the Liver) New data presented today at the International Liver CongressTM confirm the antiviral activity of fluvastatin -- commonly used as a cholesterol-lowering treatment -- in patients with chronic hepatitis C (HCV).

TOPICS:

First study in decade provides hope for patients suffering from primary biliary cirrhosis

March 31, 2011 8:39 am | by EurekAlert | Comments

(European Association for the Study of the Liver) Results from an international study presented today at the International Liver Congress have shown Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated...

TOPICS:

Lymphocyte-hepatocyte interactions: hepatitis C virus changes the rules

March 31, 2011 8:39 am | by EurekAlert | Comments

(European Association for the Study of the Liver) New data presented at the International Liver Congress today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.

TOPICS:

MedNet Solutions Announces the Release of iMedNet EDC

March 31, 2011 8:37 am | by Bio-Medicine.Org | Comments

MINNETONKA, Minn., March 31, 2011 /- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce that iMedNet™ EDC , the company's innovative, next-generation electronic data capture (EDC) solution,...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading